The persistence of antibodies in ESRD patients 12 months after the BNT162B2 vaccine booster dose.
End-stage renal disease (ESRD) patients undergoing haemodialysis have been reported to have impaired humoral response after coronavirus disease 2019 vaccination. However, most studies focus on one antibody profile or one-time point only. Here, we longitudinally investigate the antibody response towa...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| 格式: | Article |
| 語言: | English |
| 出版: |
UniKL Royal College of Medicine Perak (UniKL RCMP)
2024
|
| 主題: | |
| 在線閱讀: | http://irep.iium.edu.my/113313/7/113313_The%20persistence%20of%20antibodies%20in%20ESRD%20patients%2012%20months.pdf http://irep.iium.edu.my/113313/ https://www.ajmhsrcmp.org/#page/1 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|